Haemonetics Corporation (HAE)
NYSE: HAE · IEX Real-Time Price · USD
90.99
+3.33 (3.80%)
Apr 26, 2024, 4:00 PM EDT - Market closed
Haemonetics Balance Sheet
Financials in millions USD. Fiscal year is May - April.
Millions USD. Fiscal year is May - Apr.
| Year | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 - 1995 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 284.47 | 259.5 | 192.31 | 137.31 | 169.35 | 180.17 | 139.56 | 115.12 | 160.66 | 192.47 | Upgrade
|
| Cash & Cash Equivalents | 284.47 | 259.5 | 192.31 | 137.31 | 169.35 | 180.17 | 139.56 | 115.12 | 160.66 | 192.47 | Upgrade
|
| Cash Growth | 9.62% | 34.94% | 40.05% | -18.92% | -6.00% | 29.09% | 21.23% | -28.34% | -16.53% | 7.45% | Upgrade
|
| Receivables | 179.14 | 159.38 | 127.56 | 165.21 | 185.03 | 151.23 | 152.68 | 157.09 | 145.83 | 164.6 | Upgrade
|
| Inventory | 259.38 | 293.03 | 322.61 | 270.28 | 194.34 | 160.8 | 176.93 | 187.03 | 211.08 | 197.66 | Upgrade
|
| Other Current Assets | 46.74 | 44.13 | 51.07 | 30.85 | 27.41 | 28.98 | 40.85 | 28.84 | 40.1 | 68.24 | Upgrade
|
| Total Current Assets | 769.72 | 756.03 | 693.55 | 603.64 | 576.12 | 521.18 | 510.03 | 488.09 | 557.67 | 622.98 | Upgrade
|
| Property, Plant & Equipment | 310.89 | 258.48 | 217.56 | 253.4 | 343.98 | 332.16 | 323.86 | 337.63 | 321.95 | 271.44 | Upgrade
|
| Goodwill and Intangibles | 742 | 777.55 | 831.93 | 343.76 | 338.51 | 367.98 | 388.38 | 472.3 | 578.9 | 607.93 | Upgrade
|
| Other Long-Term Assets | 112.22 | 67.67 | 76.89 | 66.31 | 16.16 | 16.02 | 16.44 | 21.11 | 26.9 | 11.84 | Upgrade
|
| Total Long-Term Assets | 1,165 | 1,104 | 1,126 | 663.47 | 698.65 | 716.16 | 728.68 | 831.04 | 927.75 | 891.2 | Upgrade
|
| Total Assets | 1,935 | 1,860 | 1,820 | 1,267 | 1,275 | 1,237 | 1,239 | 1,319 | 1,485 | 1,514 | Upgrade
|
| Accounts Payable | 63.93 | 58.37 | 50.29 | 50.73 | 63.36 | 55.27 | 42.97 | 39.67 | 48.43 | 53.56 | Upgrade
|
| Current Debt | 11.78 | 214.15 | 17.02 | 76.98 | 27.67 | 194.26 | 61.02 | 43.47 | 21.52 | 45.63 | Upgrade
|
| Other Current Liabilities | 176.1 | 169.75 | 186.19 | 147.11 | 144.73 | 135.18 | 107.18 | 102.41 | 118.74 | 117.74 | Upgrade
|
| Total Current Liabilities | 251.82 | 442.27 | 253.5 | 274.82 | 235.76 | 384.7 | 211.18 | 185.55 | 188.68 | 216.93 | Upgrade
|
| Long-Term Debt | 754.1 | 559.44 | 690.59 | 305.51 | 322.45 | 59.42 | 253.63 | 364.53 | 406.37 | 392.06 | Upgrade
|
| Other Long-Term Liabilities | 110.91 | 108.6 | 144.17 | 99.67 | 48.69 | 40.78 | 34.3 | 47.48 | 64.24 | 67.31 | Upgrade
|
| Total Long-Term Liabilities | 865.01 | 668.04 | 834.76 | 405.18 | 371.14 | 100.21 | 287.92 | 412.01 | 470.61 | 459.36 | Upgrade
|
| Total Liabilities | 1,117 | 1,110 | 1,088 | 680 | 606.9 | 484.91 | 499.1 | 597.56 | 659.3 | 676.29 | Upgrade
|
| Total Debt | 765.89 | 773.59 | 707.61 | 382.49 | 350.12 | 253.68 | 314.65 | 408 | 427.89 | 437.69 | Upgrade
|
| Debt Growth | -1.00% | 9.32% | 85.00% | 9.25% | 38.02% | -19.38% | -22.88% | -4.65% | -2.24% | -8.83% | Upgrade
|
| Retained Earnings | 253.17 | 202.39 | 157.98 | 78.51 | 161.42 | 266.94 | 289.92 | 316.18 | 420.37 | 433.35 | Upgrade
|
| Comprehensive Income | -30.38 | -25.95 | -29.55 | -45.14 | -30.38 | -18.99 | -32.87 | -35.04 | -21.72 | 1.41 | Upgrade
|
| Shareholders' Equity | 818 | 749.42 | 731.67 | 587.11 | 667.87 | 752.43 | 739.61 | 721.57 | 826.12 | 837.89 | Upgrade
|
| Net Cash / Debt | -481.42 | -514.09 | -515.3 | -245.18 | -180.77 | -73.51 | -175.08 | -292.88 | -267.23 | -245.22 | Upgrade
|
| Net Cash Per Share | -9.36 | -10.01 | -10.05 | -4.73 | -3.41 | -1.37 | -3.40 | -5.75 | -5.13 | -4.68 | Upgrade
|
| Working Capital | 517.91 | 313.77 | 440.05 | 328.82 | 340.36 | 136.47 | 298.85 | 302.54 | 368.99 | 406.05 | Upgrade
|
| Book Value Per Share | 16.11 | 14.68 | 14.44 | 11.58 | 12.96 | 14.26 | 14.36 | 14.17 | 16.03 | 16.23 | Upgrade
|